Dr. Michael Todd Czarnecki, MD

Dr. Czarnecki practices at Tennessee Valley Healthcare System - Nashville in Nashville, Tennessee.

Dr. Czarnecki's NPI, 1780774083, was assigned on October 15, 2006. Dr. Czarnecki holds Tennessee license 44980.

Dr. Czarnecki's primary practice is Tennessee Valley Healthcare System - Nashville, at 1310 24th S Ave, Nashville, TN 37212 in Davidson County. The practice phone is (615) 321-6373.

Dr. Czarnecki's primary practice is Tennessee Valley Healthcare System - Nashville in Nashville, Tennessee. Dr. Czarnecki is also affiliated with Erlanger Baroness Hospital. The medical group on file is The Lung Docs. Dmand AI also links Dr. Czarnecki to 2 more hospitals, 2 home health agencies, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Czarnecki practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Czarnecki's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Czarnecki's licenses on file in 3 states: Tennessee, Georgia and Texas.

CMS data shows 5,579 Medicare services from Dr. Czarnecki across 15 procedure codes in 2024, for 830 Medicare patients. Medicare paid $556,646 for them.

CMS counts 830 Medicare patients who saw Dr. Czarnecki in 2024. The largest group is 75 to 84, with 310 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Czarnecki's median patient age at 72, with 62% women.

In 2024, Dr. Czarnecki wrote 6,106 Medicare Part D claims for 951 patients. 61% of them were for generic drugs. CMS names the drug for 5,623 of them, across 89 drugs with 11 or more claims each, at $6,154,821 in total drug cost. In 2023, CMS named 3,081 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Czarnecki for performance year 2024, reported individually. Dr. Czarnecki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Czarnecki as offering telehealth.

CMS Open Payments shows 1,779 general payments to Dr. Czarnecki from 59 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $279,884.